Some parts of the portal may cause error messages or display incorrectly due to the transition to a new provider of trading data

REPH - Recro Pharma Inc

Close
2.09
-0.010   -0.478%

Share volume: 141,803
Last Updated: Mon 21 Mar 2022 09:00:01 PM CET
Pharmaceutical Preparation Manufacturing : -2.88%

PREVIOUS CLOSE
CHG
CHG%
$2.10
-0.01
-0.48%
This ticker is disabled and data are no longer maintained and up to date.
Overview Charts Financials Fundamental analysis Historical prices Events Documents Notes Dividends
Fundamental analysis
43%
Profitability 53%
Dept financing 21%
Liquidity 55%
Performance 35%
Company vs Stock growth
vs
+ Add row to compare
Performance
5 Days
6.06%
1 Month
31.25%
3 Months
27.27%
6 Months
0   0%
1 Year
-41.18%
2 Year
-69.61%
Key data
Stock price
$2.09
P/E Ratio 
0.00
DAY RANGE
N/A - N/A
EPS 
$0.00
52 WEEK RANGE
$1.38 - $3.65
52 WEEK CHANGE
-$0.41
MARKET CAP 
117.927 M
YIELD 
N/A
SHARES OUTSTANDING 
56.424 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
05/05/2022
BETA 
1.06
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$83,085
AVERAGE 30 VOLUME 
$121,330
Company detail
CEO:
Region: US
Website: www.recropharma.com
Employees: 185
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Pharmaceutical Preparation Manufacturing
Sector: Manufacturing

Recro Pharma Inc. is a contract development and manufacturing organization (CDMO) with capabilities from early feasibility to commercial manufacturing. With an expertise in solving complex manufacturing problems, Recro is a leading CDMO providing oral solid dosage form development, end-to-end regulatory support, clinical and commercial manufacturing, and packaging and logistics services to the global pharmaceutical market.

Recent news